What are the comparative benefits and harms of early HRT formulations versus current formulations?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18258257
Cited by: 0

Abstract

While both early and current HRT formulations effectively manage menopausal symptoms, newer formulations, especially transdermal options, may offer reduced risk for cardiovascular disease and breast cancer compared to older oral formulations, provided treatment initiation is appropriately timed.

Fields of Study & Subjects

Menopause: Health Impacts and Treatments Estrogen and related hormone effects Hormonal and reproductive studies

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
14 January 2026